- Protinádorový synergismus mezi venetoklaxem a azacytidinem2021 | First Faculty of Medicine
- Time-limited therapy with the combination of venetoclax and obinutuzumab in the first-line treatment of chronic lymphocytic leukemia2023 | Publication without faculty affiliation
- Treatment of relapsed chronic lymphocytic leukemia2019 | First Faculty of Medicine
- Terapie azacytidinem v kombinaci s venetoklaxem - nový směr v léčbě akutní myeloidní leukemie2022 | First Faculty of Medicine
- Treatment of repeatedly relapsing chronic lymphocytic leukemia2018 | Faculty of Medicine in Hradec Králové
- Richter transformation of chronic lymphocytic leukaemia in the era of treatment with B-cell signalling pathway inhibitors2020 | First Faculty of Medicine
- Modern approach to the treatment of chronic lymphocytic leukemia2023 | Faculty of Medicine in Hradec Králové
- Nové léčebné postupy u chronické lymfocytární leukemie2017 | First Faculty of Medicine
- Use of ibrutinib as "bridging" for allogeneic hematopoietic stem cell transplantation from haploidentic donor and subsequent therapy of residual disease after transplantation in a patient with highly adverse mantle cell lymphoma2019 | First Faculty of Medicine
- Current possibilities of diffuse large cell lymphoma2019 | First Faculty of Medicine
- Recommendations for chronic lymphocytic leukaemia diagnosis and therapy 20212021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Treatment of elderly and comorbid patients with chronic lymphocytic leukemia2017 | Faculty of Medicine in Hradec Králové
- New trends in the multiple myeloma treatment2019 | First Faculty of Medicine
- Bruton's tyrosine kinase inhibitors and their current status in the treatment of chronic lymphocytic leukemia2023 | First Faculty of Medicine
- Development of Richter's transformation in a patient with refractory chronic lymphocytic leukaemia on ibrutinib therapy2020 | Faculty of Medicine in Hradec Králové
